Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
10 years of interferon beta-1b (Beta feron therapy.
European Medicines Agency accepts Marketing Authorization Application for conditional approval of masitinib in the treatment of pancreatic cancer
Antagonism of histamine H4 receptor exacerbates clinical and pathological signs of experimental autoimmune encephalomyelitis.
Burden of neurological conditions in Canada.
Gastro Effects Dog Oral MS Drug Tecfidera
A Cross-Sectional Study of the Impact of Spasticity on Daily Activities in Multiple Sclerosis.
Fatigue and Comorbidities in Multiple Sclerosis.
Magnetic resonance imaging outcomes from a phase III trial of teriflunomide.
Management of multiple sclerosis and the integration of related specialty pharmacy programs within health systems.
Teriflunomide
Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.
Cervical cord and ventricle affection in neuromyelitis optica.
In vivo and in vitro effects of multiple sclerosis immunomodulatory therapeutics on glutamatergic excitotoxicity.
PML in a patient treated with dimethyl fumarate from a compounding pharmacy.
Treatment Burden and Chronic Illness: Who is at Most Risk?
New Data Show Strong, Sustained Effects of TECFIDERA® (Dimethyl Fumarate) in Newly-Diagnosed and Early Disease Course Multiple Sclerosis Patients
Imidazol-1-ylethylindazole voltage-gated sodium channel ligands are neuroprotective during optic neuritis in a mouse model of multiple sclerosis.
The use of hematopoietic stem cells in autoimmune diseases.
An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination.
Effect of smoking on multiple sclerosis: a meta-analysis.
Dimethyl fumarate induces necroptosis in colon cancer cells through glutathione depletion/ROS increase/MAPKs activation pathway.
Geography in multiple sclerosis.
Daclizumab in multiple sclerosis: a high-yield extension study.
Recent insights into the mechanism of action of glatiramer acetate.
Multiple sclerosis: Could Helicobacter pylori provide protection against multiple sclerosis?
Pages
« first
‹ previous
…
36
37
38
39
40
41
42
43
44
…
next ›
last »